Cost analysis of lurasidone for the treatment of schizophrenia in adolescents and adults within the United Kingdom

BACKGROUND: Schizophrenia is a serious mental health condition characterised by distortions in thought processes, perception, mood, sense of self, and behaviour. Lurasidone, a second-generation atypical antipsychotic, represents an additional treatment option alongside existing antipsychotics for ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Dymond, Amy, Afonso, Daniela, Green, Will
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404623/
https://www.ncbi.nlm.nih.gov/pubmed/36002828
http://dx.doi.org/10.1186/s12913-022-08436-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404623/
https://www.ncbi.nlm.nih.gov/pubmed/36002828
http://dx.doi.org/10.1186/s12913-022-08436-x

Ejemplares similares